Table 1.
Endpoint | Conclusion | Literature review | GRADE level |
---|---|---|---|
Overall survival | RFA (± PH) + chemotherapy is superior to chemotherapy alone | 1 RCT (downgraded; serious imprecision)a | Moderate |
RFA + chemotherapy is superior to chemotherapy alone | 1 RCT (downgraded 2x; serious indirectnessb and serious imprecision)a | Low | |
RFA (for unresectable CRLM) + PH is equivalent to PH alone | Observational comparative studies | Very low | |
RFA alone (for unresectable CRLM) is inferior to PH alone | Observational comparative studies | Very low | |
MWA is equivalent to PH | 1 RCT (downgraded; very serious risk of bias) | Very low | |
MWA (for unresectable CRLM) + PH is equivalent to PH alone | One observational comparative study | Very low | |
Complications | RFA alone (for unresectable CRLM) is superior to PH | Observational comparative studies | Very low |
Studies on RFA (for unresectable CRLM) + PH versus PH alone show conflicting results | Observational comparative studies | – | |
MWA alone is equivalent to PH | 1 RCT (downgraded; very serious risk of bias) | Very low | |
Quality of life | There are no comparative studies on the effect of RFA or MWA | – | – |
*GRADE definitions: high quality—further research is very unlikely to change our confidence in the estimate of effect (randomized controlled trials); moderate quality—further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate (controlled trials, no randomization), low quality—further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate (observational studies); very low quality—any estimate of effect is very uncertain (any other type)
aserious imprecision: in case of low optimal information size (OIS; number of included patients did not meet sample size), dichotomous outcomes, low number of events, wide confidence intervals with uncertainty about magnitude of effect, or when there is a lot of variation in the effects among the participants in continious measures
bserious indirectness: very important differences in populations, interventions, outcome measures, or indirect comparisons